Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide.
about
Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion.Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells.Update on cytogenetic and molecular changes in myelodysplastic syndromes.Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomesTechniques for detecting chromosomal aberrations in myelodysplastic syndromesConcurrence of chromosome 3 and 4 aberrations in human uveal melanoma.Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.
P2860
Q36612675-11BAB94E-018F-49A2-871E-2199CDE29D76Q37365459-3CAF87B7-AA35-4A59-91DA-FBA36DEFE872Q37410210-4246C568-4357-4B67-B1B2-04C76B03A79EQ37923939-1F179891-CC80-49C1-99B2-D55E1CD6A06FQ38135713-98969472-E633-44E9-9F82-806A3B3FF38AQ41791233-7265DE32-9112-4344-9D5B-83A165D6ACC4Q42117021-99779C4C-A7D5-4572-89AA-77CB732309CAQ42586752-5C3ED743-9D0C-49E7-9DD2-7766C1F883C9
P2860
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cytogenetic follow-up by karyo ...... 5q treated with lenalidomide.
@en
type
label
Cytogenetic follow-up by karyo ...... 5q treated with lenalidomide.
@en
prefLabel
Cytogenetic follow-up by karyo ...... 5q treated with lenalidomide.
@en
P2093
P2860
P50
P1433
P1476
Cytogenetic follow-up by karyo ...... 5q treated with lenalidomide.
@en
P2093
Eva Hellström-Lindberg
Gudrun Göhring
Guntram Büsche
Hans Heinrich Kreipe
Winfried Hofmann
P2860
P304
P356
10.3324/HAEMATOL.2010.026658
P577
2010-11-25T00:00:00Z